-
Atrial septal defects (asd) are the most frequent congenital heart defects. Closure of the defect (either surgically or percutaneously) is a Class 1 recommendation in the ACC/AHA guidelines for management of adults with congenital heart disease when there is right heart dilation.
-
Patients presenting with acute coronary syndromes (ACS) should be administered dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel. However, some patients are subsequently found to have left main (LM) or multivessel disease (MVD) and require coronary artery bypass graft (CABG) surgery. For patients who have been loaded with clopidogrel, early CABG can result in excess bleeding:
-
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms,
-
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I.
-
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial.
-
Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
-
Thrombosis of prosthetic heart valves is one of the most feared complications of heart-valve replacement.
-
Most prior study results of catheter ablation for atrial fibrillation (AF) have had relatively short follow-up duration.